Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 33.8294.6045.00-24.35-8.75

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 33.82 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35
Mar2019-8.75

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35
Negative
Mar2019 -8.75 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹175.2 Cr -6.2% 0% 17.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 0.4% -0.4% 61.2% Stock Analytics
CIPLA ₹112,990.0 Cr -1.1% 1.7% 53.9% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 5.9% 11.3% 94.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr -0.1% 3.9% 20% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -2% -4.2% 29.3% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-6.2%

0%

17.8%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses